Incannex Company Presentation – Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
May 03, 2023 07:30 ET | Incannex Healthcare
MELBOURNE, Australia, May 03, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) is pleased to announce a company presentation containing data...
The Dry Eye Drink by Bruder
Bruder Healthcare Now Exclusive Licensor of the Dry Eye Drink™ -- First and Only Ophthalmic Anti-Inflammatory Hyper-Hydrating Drink
February 13, 2023 10:00 ET | Bruder Healthcare
ATLANTA, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Bruder Healthcare, a Hilco Vision Company, announced an exclusive licensing agreement with Baton Rouge-based Dry Eye Drink LLC, the manufacturer of a...
Animal Healthcare Market to hit USD 238 Billion by 2032, says Global Market Insights Inc.
January 11, 2023 07:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The animal healthcare market value is set to reach USD 238 billion by 2032, according to a new research report by Global Market Insights...
Companion Animal Drugs Market to hit USD 24.5 billion by 2032, says Global Market Insights Inc.
December 05, 2022 07:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The companion animal drugs market value is estimated to gains USD 24.5 billion by 2032, as per a new research report by Global Market...
Gb Sciences
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients
November 01, 2022 07:00 ET | Gb Sciences
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences, Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the...
Derm-Biome Pharmaceuticals, Inc. reports positive preclinical data in melanoma and squamous cell carcinoma, initiates a program aimed at advancing topical therapies for skin cancer to the clinic
October 12, 2022 10:00 ET | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy aging, has...
Conagen develops new compound dihydro resveratrol
Conagen’s New Dihydro Resveratrol Made By Clean Bioconversion Inspires Novel Products and Drives Market Growth
May 31, 2022 05:01 ET | Conagen
Bedford, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and...
First Wave BioPharma Forms Clinical Steering Committee Focused on Advancing Inflammatory Bowel Disease (IBD) Product Portfolio
April 27, 2022 07:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., April 27, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Graphical Research.jpg
Europe Animal Healthcare Market revenue to surpass $49.4bn by 2027, says Graphical Research
April 26, 2022 03:12 ET | Graphical Research
Pune, India, April 26, 2022 (GLOBE NEWSWIRE) -- As per a recent industry report put forward by Graphical Research, the Europe animal healthcare market is forecast to register its name in the...
Aquaculture Healthcare Market to cross $1.25 billion by 2028, Says Global Market Insights Inc.
February 02, 2022 03:35 ET | Global Market Insights Inc.
Selbyville, Delaware, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Global aquaculture healthcare market revenue is projected to cross USD 1.25 billion by 2028, according to a new research report by Global...